NPI: 1538137799 · MIAMI, FL 33150 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/14/2006
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 03/14/2006 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 20,652 | $3.24M |
| 2019 | 29,790 | $5.92M |
| 2020 | 29,213 | $5.24M |
| 2021 | 26,577 | $1.77M |
| 2022 | 6,688 | $506K |
| 2023 | 808 | $78K |
| 2024 | 180 | $19K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 37,807 | 1,468 | $5.44M |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 29,388 | 1,842 | $4.50M |
| J1270 | Injection, doxercalciferol, 1 mcg | 24,445 | 1,475 | $3.38M |
| J1756 | Injection, iron sucrose, 1 mg | 5,470 | 943 | $795K |
| A4657 | Syringe, with or without needle, each | 4,058 | 1,592 | $768K |
| 83540 | 2,127 | 1,312 | $319K | |
| 83550 | 2,127 | 1,311 | $319K | |
| 82728 | 1,986 | 1,220 | $296K | |
| 85048 | 1,912 | 1,216 | $289K | |
| 85041 | 1,920 | 1,215 | $288K | |
| 83970 | 1,786 | 736 | $271K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 359 | 187 | $36K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 329 | 197 | $36K |
| 82108 | 126 | 81 | $19K | |
| G0008 | Administration of influenza virus vaccine | 22 | 17 | $6K |
| 90674 | 20 | 15 | $6K | |
| 0004A | 12 | 12 | $1K | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 14 | 13 | $0.00 |